Sinco Pharmaceuticals Holdings Ltd. (HK:6833) has released an update.
Sinco Pharmaceuticals Holdings Ltd. announced additional information regarding a guarantee agreement, highlighting the determination of a fee rate based on comparable transactions from the Hong Kong Stock Exchange. The company has identified 14 similar transactions to ensure the fee rate is competitive and well-founded. This move underscores Sinco’s commitment to transparency and financial prudence in its connected transactions.
For further insights into HK:6833 stock, check out TipRanks’ Stock Analysis page.